Hope4Cancer utilizes a powerful, proprietary cancer treatment formulation from mistletoe, known as Iscador®. Iscador® is a proprietary cancer treatment first developed in Switzerland. One of the primary functions of Iscador® is that it stimulates parts of the immune system that can slow the growth of cancer cells and does so with very limited side effects. For this reason, it is often used in conjunction with conventional therapies such as surgery, chemotherapy and radiation therapy.

Mistletoe has been used as a medicinal plant since ancient times. It was used first specifically for cancer patients in the early 20th century, and with increasing successes in treatment since that time, its use has become widespread. In fact, over 50% of cancer patients in Germany today are treated with the plant in some form during their treatment.

Mistletoe grows on a variety of host trees, each of which yields a different type of Iscador® — Iscador® P from pine trees, Iscador® Qu from oak trees, and Iscador® M from apple trees. The different formulations are each prescribed to treat different forms of cancer.

Extensive research and clinical experience demonstrate the vast array of health benefits that Iscador® provides (Maticek et al. Use of Iscador®, An Extract of European Mistletoe (Viscum Album) in Cancer Treatment. Alternative Therapies Vol. 7, Number 3, 2001):

Other major effects:

Because of these qualities supported by strong clinical evidence, Iscador® is accepted today as an important element in the integrative therapy of cancer patients.